TY - JOUR T1 - Comparative Characterization of Stem Cell Marker Expression, Metabolic Activity and Resistance to Doxorubicin in Adherent and Spheroid Cells Derived from the Canine Prostate Adenocarcinoma Cell Line CT1258 JF - Anticancer Research JO - Anticancer Res SP - 1917 LP - 1927 VL - 35 IS - 4 AU - WEN LIU AU - MOHAMMED MOULAY AU - SASKIA WILLENBROCK AU - CATRIN ROOLF AU - CHRISTIAN JUNGHANSS AU - ANACLET NGENAZAHAYO AU - INGO NOLTE AU - HUGO MURUA ESCOBAR Y1 - 2015/04/01 UR - http://ar.iiarjournals.org/content/35/4/1917.abstract N2 - Background: Canine prostate cancer represents a spontaneous animal model for the human counterpart. Cells with stem cell-like character are considered to play a major role in therapeutic resistance and tumor relapse. Thus, the identification of markers allowing for recognition and characterization of these cells is essential. Materials and Methods: Expression of 12 stem cell marker genes in the canine prostate cancer cell line CT1258 and spheroid cells generated from these was analyzed by quantitative real-time PCR. In CT1258 and the generated spheroid cells, CD44 and CD133 expression was analyzed by flow cytometry, as well as proliferation and doxorubicin resistance. Results: Integrin alpha-6 (ITGA6) expression and metabolic activity were significantly up-regulated in CT1258-derived spheroid cells, while doxorubicin resistance remained comparable. Conclusion: ITGA6 de-regulation and metabolic activity appear to be characteristic of the generated spheres, indicating potential intervention targets. ER -